86 related articles for article (PubMed ID: 31883084)
1. Evaluating MERS-CoV Entry Pathways.
Qing E; Hantak MP; Galpalli GG; Gallagher T
Methods Mol Biol; 2020; 2099():9-20. PubMed ID: 31883084
[TBL] [Abstract][Full Text] [Related]
2. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein.
Millet JK; Whittaker GR
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15214-9. PubMed ID: 25288733
[TBL] [Abstract][Full Text] [Related]
3. IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms.
Wrensch F; Winkler M; Pöhlmann S
Viruses; 2014 Sep; 6(9):3683-98. PubMed ID: 25256397
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus.
Han Y; Ma Y; Wang Z; Feng F; Zhou L; Feng H; Ma J; Ye R; Zhang R
J Med Virol; 2024 Jun; 96(6):e29712. PubMed ID: 38808555
[TBL] [Abstract][Full Text] [Related]
5. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
Mollica V; Rizzo A; Massari F
Future Oncol; 2020 Sep; 16(27):2029-2033. PubMed ID: 32658591
[No Abstract] [Full Text] [Related]
6. Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection.
Qing E; Hantak M; Perlman S; Gallagher T
mBio; 2020 Feb; 11(1):. PubMed ID: 32047128
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
8. Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning.
Lei R; Qing E; Odle A; Yuan M; Gunawardene CD; Tan TJC; So N; Ouyang WO; Wilson IA; Gallagher T; Perlman S; Wu NC; Wong LR
Nat Commun; 2024 May; 15(1):4056. PubMed ID: 38744813
[TBL] [Abstract][Full Text] [Related]
9. Monitoring HIV-1 Nuclear Import Kinetics Using a Chemically Induced Nuclear Pore Blockade Assay.
Dharan A; Campbell EM
Methods Mol Biol; 2024; 2807():141-151. PubMed ID: 38743226
[TBL] [Abstract][Full Text] [Related]
10. Adaptation of SARS-CoV-2 to ACE2
Li K; Verma A; Li P; Ortiz ME; Hawkins GM; Schnicker NJ; Szachowicz PJ; Pezzulo AA; Wohlford-Lenane CL; Kicmal T; Meyerholz DK; Gallagher T; Perlman S; McCray PB
J Virol; 2024 Jan; 98(1):e0151023. PubMed ID: 38168680
[TBL] [Abstract][Full Text] [Related]
11. A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs.
Dey D; Qing E; He Y; Chen Y; Jennings B; Cohn W; Singh S; Gakhar L; Schnicker NJ; Pierce BG; Whitelegge JP; Doray B; Orban J; Gallagher T; Hasan SS
Nat Commun; 2023 Dec; 14(1):8358. PubMed ID: 38102143
[TBL] [Abstract][Full Text] [Related]
12. Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning.
Lei R; Qing E; Odle A; Yuan M; Tan TJC; So N; Ouyang WO; Wilson IA; Gallagher T; Perlman S; Wu NC; Wong LR
bioRxiv; 2023 Nov; ():. PubMed ID: 38076875
[TBL] [Abstract][Full Text] [Related]
13. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages.
Qing E; Gallagher T
mBio; 2023 Aug; 14(4):e0017123. PubMed ID: 37382441
[TBL] [Abstract][Full Text] [Related]
14. DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner.
Strine MS; Cai WL; Wei J; Alfajaro MM; Filler RB; Biering SB; Sarnik S; Chow RD; Patil A; Cervantes KS; Collings CK; DeWeirdt PC; Hanna RE; Schofield K; Hulme C; Konermann S; Doench JG; Hsu PD; Kadoch C; Yan Q; Wilen CB
PLoS Biol; 2023 Jun; 21(6):e3002097. PubMed ID: 37310920
[TBL] [Abstract][Full Text] [Related]
15. Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
Sengar A; Cervantes M; Bondalapati ST; Hess T; Kasson PM
J Virol; 2023 May; 97(5):e0199222. PubMed ID: 37133381
[TBL] [Abstract][Full Text] [Related]
16. Systematic Tracing of Susceptible Animals to SARS-CoV-2 by a Bioinformatics Framework.
Sun H; Wang A; Wang L; Wang B; Tian G; Yang J; Liao M
Front Microbiol; 2022; 13():781770. PubMed ID: 35308363
[TBL] [Abstract][Full Text] [Related]
17. Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.
Mast FD; Fridy PC; Ketaren NE; Wang J; Jacobs EY; Olivier JP; Sanyal T; Molloy KR; Schmidt F; Rutkowska M; Weisblum Y; Rich LM; Vanderwall ER; Dambrauskas N; Vigdorovich V; Keegan S; Jiler JB; Stein ME; Olinares PDB; Herlands L; Hatziioannou T; Sather DN; Debley JS; Fenyö D; Sali A; Bieniasz PD; Aitchison JD; Chait BT; Rout MP
Elife; 2021 Dec; 10():. PubMed ID: 34874007
[TBL] [Abstract][Full Text] [Related]
18.
Xu F; Gao J; Orgil BO; Bajpai AK; Gu Q; Purevjav E; Davenport AS; Li K; Towbin JA; Black DD; Pierre JF; Lu L
J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834564
[TBL] [Abstract][Full Text] [Related]
19. A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses.
Nassar A; Ibrahim IM; Amin FG; Magdy M; Elgharib AM; Azzam EB; Nasser F; Yousry K; Shamkh IM; Mahdy SM; Elfiky AA
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770863
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
